Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays the updated platform revision (v3.7.0) in place of the previous v3.6.6, indicating a site-wide update without altering the study details.
    Difference
    0.1%
    Check dated 2026-09-15T23:53:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page footer now displays a new revision tag (v3.6.6) and the previous revision tag (v3.6.5) along with related attribution text were removed. This is a minor administrative update to site metadata and does not change the study details.
    Difference
    0.2%
    Check dated 2026-09-01T20:03:50.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a new version of the page. This update is administrative and does not alter the study content presented.
    Difference
    0.1%
    Check dated 2026-08-11T15:48:44.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new Nat Commun publication citation was added to the Publications section, including the full citation and DOI. The update also removes the 'Online ahead of print' note from the previous reference and adds a 'Revision: v3.6.4' tag.
    Difference
    0.1%
    Check dated 2026-07-28T05:26:19.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page's revision history indicates a new revision tag (v3.6.3) was added with dates 2026-07-02 and 2026-06-30, and the previous revision v3.6.2 was removed (dates 2026-04-02 and 2026-03-31). These entries reflect backend/versioning updates rather than changes to visible content.
    Difference
    0.3%
    Check dated 2026-07-06T18:15:39.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, indicating a post-release adjustment to the page template or documentation. This represents a small internal update rather than any change to the study information presented.
    Difference
    0.1%
    Check dated 2026-06-29T14:47:15.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.